XAGE: Carmell Therapeutics Corporation Price-to-Revenue Multiple

Symbol and logo of brand Carmell Corp (XAGE)

Stable supply chains for dermatological products ensure business resilience, as confirmed by the revenue multiple for Longevity Health Holdings (XAGE). The current value of 3.90 serves as an indicator of market valuation. Partnerships with plastic surgeons to promote plasma biomaterials are driving sales growth, while Longevity Health Holdings (XAGE) accumulates its primary capital through the sale of regenerative cosmetics for tissue rejuvenation.

XAGE carmellcosmetics.com Market Cap to Revenue (04/04/2025 - 09/27/2025)

Longevity Health Holdings Inc (XAGE) - metric breakdowns and financial figures

- stock price and consensus target price:
Share Price carmellcosmetics.com|XAGE - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Longevity Health Holdings Inc|XAGE - Enterprise Value
- book capitalization data:
Net Asset Value per Share Longevity Health Holdings|XAGE - Company Net Assets|Market Value to Book Value Ratio carmellcosmetics.com|XAGE - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Longevity Health Holdings|XAGE - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Carmell Corp|XAGE - Company Total Debt|Debts to Book Value Longevity Health Holdings Inc|XAGE - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Longevity Health Holdings|Intermediate Coverage Ratio carmellcosmetics.com
- earnings and multiples data:
XAGE - Net Profit|Expected Net Profit Longevity Health Holdings|XAGE - P/E Multiple|Forward P/E Multiple Carmell Therapeutics Corporation|XAGE - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Longevity Health Holdings Inc|XAGE - Operating profit before deduction of amortization|Earnings per share for the last four quarters Longevity Health Holdings|XAGE - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months carmellcosmetics.com|XAGE - Net earnings per share growth this year|Expected earnings per share trend next year Longevity Health Holdings
- sales revenue and business income indicators:
XAGE - Revenue and Sales Volume|Company Future Revenue carmellcosmetics.com|XAGE - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Longevity Health Holdings Inc
Summary company analytics:XAGE - carmellcosmetics.com
Core merchandise of Carmell Therapeutics Corporation

The P/S multiple reflects the market value of one dollar of revenue by relating the total market capitalization of Longevity Health Holdings (XAGE) to its sales volume to assess investment attractiveness. By analyzing the price-to-sales dynamics, an investor can discern market expectations for business scaling within aesthetic medicine, where the high margins of patented products ensure sustainable revenue growth regardless of macroeconomic cycles.

Who Longevity Health Holdings competes with

hcahealthcare.com - Market Cap to Revenue Ratio|P/S Multiple THC (Tenet Healthcare Corporation)|Price-to-Revenue Multiple Fresenius Medical Care AG|Solventum Inc. - P/S Multiple|Price to Sales Encompass|UHS (uhsinc.com) - Market Cap to Revenue|DVA (davita.com) - Price-to-Revenue Ratio|RDNT (RadNet) - P/S Multiple|Option Care (OPCH) - Price-to-Revenue Coefficient|Market Cap to Revenue SGRY (Surgery Partners Corp)|Market Cap to Sales Volume PINC|National Vision Holdings - Market Cap to Revenue|progyny.com (PGNY) - Price to Sales|ARDT: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio SEM (Select Medical Corporation)|ASTH: P/S Multiple|MEDNAX - Market Capitalization-to-Revenue Ratio|USPH (US Physical Therapy) - P/S Multiple|Price to Sales pennantgroup.com PNTG|P/S Multiple ORGO|P/S Multiple Nutex Health Inc (NUTX)|Price-to-Revenue Ratio Auna Health AUNA|SBC Medical Group Holdings - Price-to-Revenue Ratio|EOLS: Market Cap to Revenue|chs.net - Market Cap to Sales Volume|SKIN: P/S Multiple|MediWound - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue BTMD|JYNT: Market Capitalization-to-Revenue Ratio|P/S Multiple DCGO|PIII (p3hp.org) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Gain Therapeutics GANX|EUDA Health Holdings (EUDA) - Price to Sales|BMGL - Price-to-Revenue Ratio|CLGN: Price-to-Revenue Ratio|CUPR: P/S Multiple|Market Cap to Revenue Ratio CCM|AMS (American Shared Hospital Services) - P/S Multiple|MEDIROM Healthcare Group Inc. (MRM) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Avalon GloboCare (ALBT)|DIH Group - Market Cap to Revenue Ratio|P/S Multiple NIVF (NewGenIvf Group Limited)|Price-to-Revenue Multiple ATI Physical Therapy Inc.|CMAX - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Kindly MD Inc KDLY|MODV (LogistiCare) - Market Cap to Revenue|Market Cap to Revenue Ratio NVOS|SSY (SunLink Health Systems Inc.) - P/S Multiple|P/S Multiple imacholdings.comm